Global Monoclonal Antibody Therapeutics Market Insights and Forecast to 2031

Report ID: 1231920 | Published Date: Jan 2025 | No. of Page: 107 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Monoclonal Antibody Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Humanized Antibody
        1.2.3 Human Mouse Chimeric Antibody
    1.3 Market by Application
        1.3.1 Global Monoclonal Antibody Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Cancer
        1.3.3 Autoimmune Diseases
        1.3.4 Infection
        1.3.5 Hematological Diseases
        1.3.6 Ophthalmological Diseases
        1.3.7 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Monoclonal Antibody Therapeutics Market Perspective (2017-2028)
    2.2 Monoclonal Antibody Therapeutics Growth Trends by Region
        2.2.1 Monoclonal Antibody Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Monoclonal Antibody Therapeutics Historic Market Size by Region (2017-2022)
        2.2.3 Monoclonal Antibody Therapeutics Forecasted Market Size by Region (2023-2028)
    2.3 Monoclonal Antibody Therapeutics Market Dynamics
        2.3.1 Monoclonal Antibody Therapeutics Industry Trends
        2.3.2 Monoclonal Antibody Therapeutics Market Drivers
        2.3.3 Monoclonal Antibody Therapeutics Market Challenges
        2.3.4 Monoclonal Antibody Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Monoclonal Antibody Therapeutics Players by Revenue
        3.1.1 Global Top Monoclonal Antibody Therapeutics Players by Revenue (2017-2022)
        3.1.2 Global Monoclonal Antibody Therapeutics Revenue Market Share by Players (2017-2022)
    3.2 Global Monoclonal Antibody Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Monoclonal Antibody Therapeutics Revenue
    3.4 Global Monoclonal Antibody Therapeutics Market Concentration Ratio
        3.4.1 Global Monoclonal Antibody Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Monoclonal Antibody Therapeutics Revenue in 2021
    3.5 Monoclonal Antibody Therapeutics Key Players Head office and Area Served
    3.6 Key Players Monoclonal Antibody Therapeutics Product Solution and Service
    3.7 Date of Enter into Monoclonal Antibody Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Monoclonal Antibody Therapeutics Breakdown Data by Type
    4.1 Global Monoclonal Antibody Therapeutics Historic Market Size by Type (2017-2022)
    4.2 Global Monoclonal Antibody Therapeutics Forecasted Market Size by Type (2023-2028)
5 Monoclonal Antibody Therapeutics Breakdown Data by Application
    5.1 Global Monoclonal Antibody Therapeutics Historic Market Size by Application (2017-2022)
    5.2 Global Monoclonal Antibody Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Monoclonal Antibody Therapeutics Market Size (2017-2028)
    6.2 North America Monoclonal Antibody Therapeutics Market Size by Type
        6.2.1 North America Monoclonal Antibody Therapeutics Market Size by Type (2017-2022)
        6.2.2 North America Monoclonal Antibody Therapeutics Market Size by Type (2023-2028)
        6.2.3 North America Monoclonal Antibody Therapeutics Market Share by Type (2017-2028)
    6.3 North America Monoclonal Antibody Therapeutics Market Size by Application
        6.3.1 North America Monoclonal Antibody Therapeutics Market Size by Application (2017-2022)
        6.3.2 North America Monoclonal Antibody Therapeutics Market Size by Application (2023-2028)
        6.3.3 North America Monoclonal Antibody Therapeutics Market Share by Application (2017-2028)
    6.4 North America Monoclonal Antibody Therapeutics Market Size by Country
        6.4.1 North America Monoclonal Antibody Therapeutics Market Size by Country (2017-2022)
        6.4.2 North America Monoclonal Antibody Therapeutics Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Monoclonal Antibody Therapeutics Market Size (2017-2028)
    7.2 Europe Monoclonal Antibody Therapeutics Market Size by Type
        7.2.1 Europe Monoclonal Antibody Therapeutics Market Size by Type (2017-2022)
        7.2.2 Europe Monoclonal Antibody Therapeutics Market Size by Type (2023-2028)
        7.2.3 Europe Monoclonal Antibody Therapeutics Market Share by Type (2017-2028)
    7.3 Europe Monoclonal Antibody Therapeutics Market Size by Application
        7.3.1 Europe Monoclonal Antibody Therapeutics Market Size by Application (2017-2022)
        7.3.2 Europe Monoclonal Antibody Therapeutics Market Size by Application (2023-2028)
        7.3.3 Europe Monoclonal Antibody Therapeutics Market Share by Application (2017-2028)
    7.4 Europe Monoclonal Antibody Therapeutics Market Size by Country
        7.4.1 Europe Monoclonal Antibody Therapeutics Market Size by Country (2017-2022)
        7.4.2 Europe Monoclonal Antibody Therapeutics Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Monoclonal Antibody Therapeutics Market Size (2017-2028)
    8.2 Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Type
        8.2.1 Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Monoclonal Antibody Therapeutics Market Share by Type (2017-2028)
    8.3 Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Application
        8.3.1 Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Monoclonal Antibody Therapeutics Market Share by Application (2017-2028)
    8.4 Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Region
        8.4.1 Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Monoclonal Antibody Therapeutics Market Size (2017-2028)
    9.2 Latin America Monoclonal Antibody Therapeutics Market Size by Type
        9.2.1 Latin America Monoclonal Antibody Therapeutics Market Size by Type (2017-2022)
        9.2.2 Latin America Monoclonal Antibody Therapeutics Market Size by Type (2023-2028)
        9.2.3 Latin America Monoclonal Antibody Therapeutics Market Share by Type (2017-2028)
    9.3 Latin America Monoclonal Antibody Therapeutics Market Size by Application
        9.3.1 Latin America Monoclonal Antibody Therapeutics Market Size by Application (2017-2022)
        9.3.2 Latin America Monoclonal Antibody Therapeutics Market Size by Application (2023-2028)
        9.3.3 Latin America Monoclonal Antibody Therapeutics Market Share by Application (2017-2028)
    9.4 Latin America Monoclonal Antibody Therapeutics Market Size by Country
        9.4.1 Latin America Monoclonal Antibody Therapeutics Market Size by Country (2017-2022)
        9.4.2 Latin America Monoclonal Antibody Therapeutics Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Monoclonal Antibody Therapeutics Market Size (2017-2028)
    10.2 Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Type
        10.2.1 Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Monoclonal Antibody Therapeutics Market Share by Type (2017-2028)
    10.3 Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Application
        10.3.1 Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Monoclonal Antibody Therapeutics Market Share by Application (2017-2028)
    10.4 Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Country
        10.4.1 Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Bayer
        11.1.1 Bayer Company Details
        11.1.2 Bayer Business Overview
        11.1.3 Bayer Monoclonal Antibody Therapeutics Introduction
        11.1.4 Bayer Revenue in Monoclonal Antibody Therapeutics Business (2017-2022)
        11.1.5 Bayer Recent Developments
    11.2 F. Hoffmann-La Roche
        11.2.1 F. Hoffmann-La Roche Company Details
        11.2.2 F. Hoffmann-La Roche Business Overview
        11.2.3 F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Introduction
        11.2.4 F. Hoffmann-La Roche Revenue in Monoclonal Antibody Therapeutics Business (2017-2022)
        11.2.5 F. Hoffmann-La Roche Recent Developments
    11.3 Pfizer
        11.3.1 Pfizer Company Details
        11.3.2 Pfizer Business Overview
        11.3.3 Pfizer Monoclonal Antibody Therapeutics Introduction
        11.3.4 Pfizer Revenue in Monoclonal Antibody Therapeutics Business (2017-2022)
        11.3.5 Pfizer Recent Developments
    11.4 Sanofi
        11.4.1 Sanofi Company Details
        11.4.2 Sanofi Business Overview
        11.4.3 Sanofi Monoclonal Antibody Therapeutics Introduction
        11.4.4 Sanofi Revenue in Monoclonal Antibody Therapeutics Business (2017-2022)
        11.4.5 Sanofi Recent Developments
    11.5 GlaxoSmithKline
        11.5.1 GlaxoSmithKline Company Details
        11.5.2 GlaxoSmithKline Business Overview
        11.5.3 GlaxoSmithKline Monoclonal Antibody Therapeutics Introduction
        11.5.4 GlaxoSmithKline Revenue in Monoclonal Antibody Therapeutics Business (2017-2022)
        11.5.5 GlaxoSmithKline Recent Developments
    11.6 Merck
        11.6.1 Merck Company Details
        11.6.2 Merck Business Overview
        11.6.3 Merck Monoclonal Antibody Therapeutics Introduction
        11.6.4 Merck Revenue in Monoclonal Antibody Therapeutics Business (2017-2022)
        11.6.5 Merck Recent Developments
    11.7 Novartis
        11.7.1 Novartis Company Details
        11.7.2 Novartis Business Overview
        11.7.3 Novartis Monoclonal Antibody Therapeutics Introduction
        11.7.4 Novartis Revenue in Monoclonal Antibody Therapeutics Business (2017-2022)
        11.7.5 Novartis Recent Developments
    11.8 AbbVie
        11.8.1 AbbVie Company Details
        11.8.2 AbbVie Business Overview
        11.8.3 AbbVie Monoclonal Antibody Therapeutics Introduction
        11.8.4 AbbVie Revenue in Monoclonal Antibody Therapeutics Business (2017-2022)
        11.8.5 AbbVie Recent Developments
    11.9 Amgen
        11.9.1 Amgen Company Details
        11.9.2 Amgen Business Overview
        11.9.3 Amgen Monoclonal Antibody Therapeutics Introduction
        11.9.4 Amgen Revenue in Monoclonal Antibody Therapeutics Business (2017-2022)
        11.9.5 Amgen Recent Developments
    11.10 Johnson & Johnson
        11.10.1 Johnson & Johnson Company Details
        11.10.2 Johnson & Johnson Business Overview
        11.10.3 Johnson & Johnson Monoclonal Antibody Therapeutics Introduction
        11.10.4 Johnson & Johnson Revenue in Monoclonal Antibody Therapeutics Business (2017-2022)
        11.10.5 Johnson & Johnson Recent Developments
    11.11 Bristol-Myers Squibb Company
        11.11.1 Bristol-Myers Squibb Company Company Details
        11.11.2 Bristol-Myers Squibb Company Business Overview
        11.11.3 Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Introduction
        11.11.4 Bristol-Myers Squibb Company Revenue in Monoclonal Antibody Therapeutics Business (2017-2022)
        11.11.5 Bristol-Myers Squibb Company Recent Developments
    11.12 Biogen
        11.12.1 Biogen Company Details
        11.12.2 Biogen Business Overview
        11.12.3 Biogen Monoclonal Antibody Therapeutics Introduction
        11.12.4 Biogen Revenue in Monoclonal Antibody Therapeutics Business (2017-2022)
        11.12.5 Biogen Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
List of Tables
    Table 1. Global Monoclonal Antibody Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Humanized Antibody
    Table 3. Key Players of Human Mouse Chimeric Antibody
    Table 4. Global Monoclonal Antibody Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Monoclonal Antibody Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Monoclonal Antibody Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Monoclonal Antibody Therapeutics Market Share by Region (2017-2022)
    Table 8. Global Monoclonal Antibody Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Monoclonal Antibody Therapeutics Market Share by Region (2023-2028)
    Table 10. Monoclonal Antibody Therapeutics Market Trends
    Table 11. Monoclonal Antibody Therapeutics Market Drivers
    Table 12. Monoclonal Antibody Therapeutics Market Challenges
    Table 13. Monoclonal Antibody Therapeutics Market Restraints
    Table 14. Global Monoclonal Antibody Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Monoclonal Antibody Therapeutics Revenue Share by Players (2017-2022)
    Table 16. Global Top Monoclonal Antibody Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibody Therapeutics as of 2021)
    Table 17. Ranking of Global Top Monoclonal Antibody Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Monoclonal Antibody Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Monoclonal Antibody Therapeutics Product Solution and Service
    Table 21. Date of Enter into Monoclonal Antibody Therapeutics Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Monoclonal Antibody Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Monoclonal Antibody Therapeutics Revenue Market Share by Type (2017-2022)
    Table 25. Global Monoclonal Antibody Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Monoclonal Antibody Therapeutics Revenue Market Share by Type (2023-2028)
    Table 27. Global Monoclonal Antibody Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Monoclonal Antibody Therapeutics Revenue Share by Application (2017-2022)
    Table 29. Global Monoclonal Antibody Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Monoclonal Antibody Therapeutics Revenue Share by Application (2023-2028)
    Table 31. North America Monoclonal Antibody Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America Monoclonal Antibody Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America Monoclonal Antibody Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America Monoclonal Antibody Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America Monoclonal Antibody Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Monoclonal Antibody Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Monoclonal Antibody Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe Monoclonal Antibody Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe Monoclonal Antibody Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe Monoclonal Antibody Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe Monoclonal Antibody Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe Monoclonal Antibody Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific Monoclonal Antibody Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Monoclonal Antibody Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Monoclonal Antibody Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Monoclonal Antibody Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Monoclonal Antibody Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Monoclonal Antibody Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Monoclonal Antibody Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America Monoclonal Antibody Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America Monoclonal Antibody Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America Monoclonal Antibody Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America Monoclonal Antibody Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America Monoclonal Antibody Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa Monoclonal Antibody Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa Monoclonal Antibody Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Monoclonal Antibody Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Monoclonal Antibody Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Monoclonal Antibody Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Monoclonal Antibody Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Bayer Company Details
    Table 62. Bayer Business Overview
    Table 63. Bayer Monoclonal Antibody Therapeutics Product
    Table 64. Bayer Revenue in Monoclonal Antibody Therapeutics Business (2017-2022) & (US$ Million)
    Table 65. Bayer Recent Developments
    Table 66. F. Hoffmann-La Roche Company Details
    Table 67. F. Hoffmann-La Roche Business Overview
    Table 68. F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Product
    Table 69. F. Hoffmann-La Roche Revenue in Monoclonal Antibody Therapeutics Business (2017-2022) & (US$ Million)
    Table 70. F. Hoffmann-La Roche Recent Developments
    Table 71. Pfizer Company Details
    Table 72. Pfizer Business Overview
    Table 73. Pfizer Monoclonal Antibody Therapeutics Product
    Table 74. Pfizer Revenue in Monoclonal Antibody Therapeutics Business (2017-2022) & (US$ Million)
    Table 75. Pfizer Recent Developments
    Table 76. Sanofi Company Details
    Table 77. Sanofi Business Overview
    Table 78. Sanofi Monoclonal Antibody Therapeutics Product
    Table 79. Sanofi Revenue in Monoclonal Antibody Therapeutics Business (2017-2022) & (US$ Million)
    Table 80. Sanofi Recent Developments
    Table 81. GlaxoSmithKline Company Details
    Table 82. GlaxoSmithKline Business Overview
    Table 83. GlaxoSmithKline Monoclonal Antibody Therapeutics Product
    Table 84. GlaxoSmithKline Revenue in Monoclonal Antibody Therapeutics Business (2017-2022) & (US$ Million)
    Table 85. GlaxoSmithKline Recent Developments
    Table 86. Merck Company Details
    Table 87. Merck Business Overview
    Table 88. Merck Monoclonal Antibody Therapeutics Product
    Table 89. Merck Revenue in Monoclonal Antibody Therapeutics Business (2017-2022) & (US$ Million)
    Table 90. Merck Recent Developments
    Table 91. Novartis Company Details
    Table 92. Novartis Business Overview
    Table 93. Novartis Monoclonal Antibody Therapeutics Product
    Table 94. Novartis Revenue in Monoclonal Antibody Therapeutics Business (2017-2022) & (US$ Million)
    Table 95. Novartis Recent Developments
    Table 96. AbbVie Company Details
    Table 97. AbbVie Business Overview
    Table 98. AbbVie Monoclonal Antibody Therapeutics Product
    Table 99. AbbVie Revenue in Monoclonal Antibody Therapeutics Business (2017-2022) & (US$ Million)
    Table 100. AbbVie Recent Developments
    Table 101. Amgen Company Details
    Table 102. Amgen Business Overview
    Table 103. Amgen Monoclonal Antibody Therapeutics Product
    Table 104. Amgen Revenue in Monoclonal Antibody Therapeutics Business (2017-2022) & (US$ Million)
    Table 105. Amgen Recent Developments
    Table 106. Johnson & Johnson Company Details
    Table 107. Johnson & Johnson Business Overview
    Table 108. Johnson & Johnson Monoclonal Antibody Therapeutics Product
    Table 109. Johnson & Johnson Revenue in Monoclonal Antibody Therapeutics Business (2017-2022) & (US$ Million)
    Table 110. Johnson & Johnson Recent Developments
    Table 111. Bristol-Myers Squibb Company Company Details
    Table 112. Bristol-Myers Squibb Company Business Overview
    Table 113. Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Product
    Table 114. Bristol-Myers Squibb Company Revenue in Monoclonal Antibody Therapeutics Business (2017-2022) & (US$ Million)
    Table 115. Bristol-Myers Squibb Company Recent Developments
    Table 116. Biogen Company Details
    Table 117. Biogen Business Overview
    Table 118. Biogen Monoclonal Antibody Therapeutics Product
    Table 119. Biogen Revenue in Monoclonal Antibody Therapeutics Business (2017-2022) & (US$ Million)
    Table 120. Biogen Recent Developments
    Table 121. Research Programs/Design for This Report
    Table 122. Key Data Information from Secondary Sources
    Table 123. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Monoclonal Antibody Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. Humanized Antibody Features
    Figure 3. Human Mouse Chimeric Antibody Features
    Figure 4. Global Monoclonal Antibody Therapeutics Market Share by Application: 2021 VS 2028
    Figure 5. Cancer Case Studies
    Figure 6. Autoimmune Diseases Case Studies
    Figure 7. Infection Case Studies
    Figure 8. Hematological Diseases Case Studies
    Figure 9. Ophthalmological Diseases Case Studies
    Figure 10. Others Case Studies
    Figure 11. Monoclonal Antibody Therapeutics Report Years Considered
    Figure 12. Global Monoclonal Antibody Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Monoclonal Antibody Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Monoclonal Antibody Therapeutics Market Share by Region: 2021 VS 2028
    Figure 15. Global Monoclonal Antibody Therapeutics Market Share by Players in 2021
    Figure 16. Global Top Monoclonal Antibody Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibody Therapeutics as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Monoclonal Antibody Therapeutics Revenue in 2021
    Figure 18. North America Monoclonal Antibody Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 19. North America Monoclonal Antibody Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 20. North America Monoclonal Antibody Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 21. North America Monoclonal Antibody Therapeutics Market Size Share by Country (2017-2028)
    Figure 22. United States Monoclonal Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Canada Monoclonal Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Monoclonal Antibody Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 25. Europe Monoclonal Antibody Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 26. Europe Monoclonal Antibody Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 27. Europe Monoclonal Antibody Therapeutics Market Size Share by Country (2017-2028)
    Figure 28. Germany Monoclonal Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. France Monoclonal Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. U.K. Monoclonal Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Italy Monoclonal Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Russia Monoclonal Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Nordic Countries Monoclonal Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Monoclonal Antibody Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 35. Asia Pacific Monoclonal Antibody Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 36. Asia Pacific Monoclonal Antibody Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 37. Asia Pacific Monoclonal Antibody Therapeutics Market Size Share by Region (2017-2028)
    Figure 38. China Monoclonal Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Japan Monoclonal Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. South Korea Monoclonal Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Southeast Asia Monoclonal Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. India Monoclonal Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Australia Monoclonal Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Latin America Monoclonal Antibody Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 45. Latin America Monoclonal Antibody Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 46. Latin America Monoclonal Antibody Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 47. Latin America Monoclonal Antibody Therapeutics Market Size Share by Country (2017-2028)
    Figure 48. Mexico Monoclonal Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Brazil Monoclonal Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 50. Middle East & Africa Monoclonal Antibody Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 51. Middle East and Africa Monoclonal Antibody Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 52. Middle East and Africa Monoclonal Antibody Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 53. Middle East and Africa Monoclonal Antibody Therapeutics Market Size Share by Country (2017-2028)
    Figure 54. Turkey Monoclonal Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Saudi Arabia Monoclonal Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. UAE Monoclonal Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 57. Bayer Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2017-2022)
    Figure 58. F. Hoffmann-La Roche Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2017-2022)
    Figure 59. Pfizer Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2017-2022)
    Figure 60. Sanofi Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2017-2022)
    Figure 61. GlaxoSmithKline Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2017-2022)
    Figure 62. Merck Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2017-2022)
    Figure 63. Novartis Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2017-2022)
    Figure 64. AbbVie Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2017-2022)
    Figure 65. Amgen Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2017-2022)
    Figure 66. Johnson & Johnson Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2017-2022)
    Figure 67. Bristol-Myers Squibb Company Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2017-2022)
    Figure 68. Biogen Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2017-2022)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Bayer
F. Hoffmann-La Roche
Pfizer
Sanofi
GlaxoSmithKline
Merck
Novartis
AbbVie
Amgen
Johnson & Johnson
Bristol-Myers Squibb Company
Biogen
Frequently Asked Questions
Monoclonal Antibody Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Monoclonal Antibody Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Monoclonal Antibody Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Potassic Fertilizer

Potassic Fertilizer market is segmented by Type and by Application. Players, stakeholders, and ot ... Read More

Personal Alarm

Personal Alarm market is segmented by Type and by Application. Players, stakeholders, and other p ... Read More